AKESOgen
Norcross
About AKESOgen
AKESOgen is an integrated genomics, genetics and biobanking company that services the pharmaceutical, biotechnology, clinical, academic, and government sectors for clinical trials, diagnostic clinical testing and research. Based in greater Atlanta, GA, the company’s initial focus has been oncology and personalized medicine. AKESOgen’s Research Services and Clinical/Regulatory Services include providing high-throughput biomarker profiling, cytogenomic arrays, sequencing (both NGS and Sanger), genotyping and epigenomic analysis utilizing different types of markers (e.g. DNA, mRNA, miRNA, and methylation) to CLIA/GLP standards. Their expertise in genomics and process control as well as their customer commitment make AKESOgen an ideal partner to execute and deliver on your projects.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $1.8M
- Funding stage: M&A
- Last round: Series Unknown (Apr 2019)
- Website: akesogen.com
- Phone: 770.542.0890
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/akesogen-130773 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.